Because high levels of CD8+ T cell infiltration have been shown to facilitate tumor treatment in tumors such as breast cancer and uroepithelial carcinoma (Sharma et al., 2007; Mahmoud et al., 2011). This evidence concerns the gene CD8A and breast carcinoma.